Fundraising Fox
/Companies
Sign in

Spark Therapeutics

Philadelphia, US · Founded 2013 · 3 known investors

Find your way into Spark Therapeutics

Sign up to find every way you can get introduced to Spark Therapeutics

  • Your email: who you already know at Spark Therapeutics, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Spark Therapeutics team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

One-time gene therapy products including a candidate for RPE65-related blindness. (NASDAQ: ONCE) (Acquired by Roche)

Biotech

Founders & leadership

Spark Therapeutics was founded in 2013 by Jeffrey D. Marrazzo.

JD
Jeffrey D. MarrazzoFounder
JWJoseph W. La Barge
Joseph W. La BargeExecutive

Board

AD
Arthur DantchikBoard director
LE
Lars Ekman, M.D. Ph.D.Board director
SM
Steven M. AltschulerBoard director
AM
Anand MehraBoard director
ES
Elliott SigalBoard director
RV
Rogerio VivaldiBoard director

Investors · 3

Deerfield Management CompanyreportedNew York

How we know: funding news · Not right? Tell us

Rock Springs CapitalreportedBaltimore

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$72.8M disclosed across 1 round · 2014

▶$72.8MraisedJun 2014 · 28 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph W. La BargeExecutive Officer
  • Elliott SigalDirector
  • Rogerio VivaldiDirector
  • Arthur DantchikDirector
  • Lars Ekman, M.D. Ph.D.Director
  • Steven M. AltschulerDirector
  • Jeffrey D. MarrazzoExecutive Officer, Director
  • Anand MehraDirector
Offering amount
$72.8M
Amount sold
$72.8M
First sale
May 2014
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Spark Therapeutics do?
One-time gene therapy products including a candidate for RPE65-related blindness. (NASDAQ: ONCE) (Acquired by Roche)
Who founded Spark Therapeutics?
Spark Therapeutics was founded by Jeffrey D. Marrazzo in 2013.
Who are Spark Therapeutics's investors?
Spark Therapeutics's investors include Sofinnova Ventures, Deerfield Management Company, Rock Springs Capital.
How much funding has Spark Therapeutics raised?
Spark Therapeutics has disclosed $72.8M raised across 1 round.
Where is Spark Therapeutics headquartered?
Spark Therapeutics is headquartered in Philadelphia, US.